Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma

Olga Lyass, Beatrice Uziely, Rami Ben‐Yosef, Dinah Tzemach, Norman I. Heshing, Michal Lotem, G Brufman, Alberto Gabizon

Cancer · 2000 · 387 citations · 29 references

DOIFull text

Open access

Abstract

The toxicity of Doxil is dose and schedule dependent and well correlated with pharmacokinetic parameters. Pharmacokinetic guidance of Doxil dosing may be a useful tool.

References

29